Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
150.56
-3.76 (-2.44%)
At close: Sep 18, 2026, 4:00 PM EDT
150.70
+0.14 (0.09%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $2.17 billion as of September 18, 2026. Its market cap has increased by 246.73% in one year.
Market Cap
2.17B
Enterprise Value
1.94B
1-Year Change
246.73%
Ranking
Category
Stock Price
$150.56
ChartMarket Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $2.17B, an increase of 1,406.80%. That is a compound annual growth rate of 368.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.17B | 75.10% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.29B |
| Aurinia Pharmaceuticals | 2.25B |
| Generate Biomedicines | 2.20B |
| Ocular Therapeutix | 2.19B |
| Trevi Therapeutics | 2.13B |
| Sarepta Therapeutics | 2.12B |
| UroGen Pharma | 2.11B |
| Biohaven | 2.06B |